ELANCO ANIMAL HEALTH INC. 2023-2024 Proxy Voting Records

Description as filed by funds: Approval of the amendment of the Articles of Incorporation to adopt a majority vote standard for uncontested elections of Directors.

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“5. Management's proposal to amend the Articles to adopt a majority vote standard for uncontested elections of directors”): 439,239,035 for, 1,491,386 against — passed, per its Form 8-K filed June 4, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved management's proposal to amend the Articles to adopt a majority vote standard for uncontested elections of directors, by the votes set forth in the table below.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 243,916,145 for, 772 abstained, 7,836 unknown.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Approval of the amendment of the Articles of Incorporation to declassify the Board of Directors.

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“4. Management's proposal to amend the Articles to declassify the Board”): 439,226,427 for, 1,488,109 against — passed, per its Form 8-K filed June 4, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved management's proposal to amend the Articles to declassify the Board, by the votes set forth in the table below.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 243,889,145 for, 772 abstained, 7,836 unknown.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: Art Garcia

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“Elect Director: Art Garcia”): 337,173,908 for, 103,570,406 against, per its Form 8-K filed June 4, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees for director nominated by the Board were elected to serve for a three-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 167,592,465 for, 76,296,680 against, 772 abstained, 7,836 unknown.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: Denise Scots-Knight

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“Elect Director: Denise Scots-Knight”): 339,982,765 for, 100,759,700 against, per its Form 8-K filed June 4, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees for director nominated by the Board were elected to serve for a three-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 168,040,420 for, 75,848,725 against, 772 abstained, 7,836 unknown.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: Jeffrey Simmons

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“Elect Director: Jeffrey Simmons”): 343,139,650 for, 97,563,208 against, per its Form 8-K filed June 4, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees for director nominated by the Board were elected to serve for a three-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 168,148,125 for, 75,741,020 against, 772 abstained, 7,836 unknown.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: William Doyle

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“Elect Director: William Doyle”): 373,318,271 for, 67,425,671 against, per its Form 8-K filed June 4, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees for director nominated by the Board were elected to serve for a three-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 209,325,673 for, 34,563,472 against, 772 abstained, 7,836 unknown.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Approval of the amendment of the Articles of Incorporation to provide shareholders with the right to amend the company's Bylaws.

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“6. Management's proposal to amend the Articles to provide shareholders with the right to amend the Company's Bylaws”): 439,290,885 for, 1,429,401 against — passed, per its Form 8-K filed June 4, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved management's proposal to amend the Articles to provide shareholders with the right to amend the Company's Bylaws, by the votes set forth in the table below.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 243,889,145 for, 772 abstained, 7,836 unknown.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Approval of the amendment of the Articles of Incorporation to provide shareholders with the right to request special meetings of shareholders.

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“7. Management's proposal to amend the Articles to provide shareholders with the right to request special meetings of shareholders”): 439,216,788 for, 1,506,358 against — passed, per its Form 8-K filed June 4, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved management's proposal to amend the Articles to provide shareholders with the right to request special meetings of shareholders, by the votes set forth in the table below.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 243,875,698 for, 40,447 against, 772 abstained, 7,836 unknown.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Advisory vote on the compensation of the company's named executive officers

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“3. By non-binding vote, the compensation of Elanco's named executive officers”): 409,526,328 for, 31,095,963 against — passed, per its Form 8-K filed June 4, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved, by non-binding vote, the compensation of Elanco's named executive officers, by the votes set forth in the table below.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 86 managers: 236,849,217 for, 7,016,215 against, 772 abstained, 7,642 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 324 managers: 311,675,944 for, 24,467,951 against, 341,304 abstained, 23,011 not voted, 194 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2024.

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“2. The appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2024”): 454,375,829 for, 1,564,686 against — passed, per its Form 8-K filed June 4, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders ratified the appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2024, by the votes set forth in the table below.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 243,889,145 for, 772 abstained, 7,836 unknown.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.